Anna Pagonakis

Array ( [id] => 5452249 [patent_doc_number] => 20090068286 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-12 [patent_title] => 'METHOD OF TREATING CANCER BY ADMINISTRATION OF 5-SUBSTITUTED NUCLEOSIDES' [patent_app_type] => utility [patent_app_number] => 11/853540 [patent_app_country] => US [patent_app_date] => 2007-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 11236 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20090068286.pdf [firstpage_image] =>[orig_patent_app_number] => 11853540 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4705185 [patent_doc_number] => 20080064709 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-13 [patent_title] => 'METHODS AND COMPOSITIONS FOR THE TREATMENT OF VASCULAR DEPRESSION' [patent_app_type] => utility [patent_app_number] => 11/852589 [patent_app_country] => US [patent_app_date] => 2007-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10511 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20080064709.pdf [firstpage_image] =>[orig_patent_app_number] => 11852589 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4859097 [patent_doc_number] => 20080267947 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'Cancer therapy with cantharidin and cantharidin analogs' [patent_app_type] => utility [patent_app_number] => 11/899687 [patent_app_country] => US [patent_app_date] => 2007-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 42674 [patent_no_of_claims] => 69 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20080267947.pdf [firstpage_image] =>[orig_patent_app_number] => 11899687 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6257084 [patent_doc_number] => 20100029609 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'BIARYL SULFONAMIDE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 12/440143 [patent_app_country] => US [patent_app_date] => 2007-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35087 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20100029609.pdf [firstpage_image] =>[orig_patent_app_number] => 12440143 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6445986 [patent_doc_number] => 20100144743 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'COMPOSITIONS AND METHODS FOR INHIBITION OF TYROSINE KINASES' [patent_app_type] => utility [patent_app_number] => 12/439402 [patent_app_country] => US [patent_app_date] => 2007-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 11583 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20100144743.pdf [firstpage_image] =>[orig_patent_app_number] => 12439402 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4840501 [patent_doc_number] => 20080280987 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-13 [patent_title] => 'Methods of inhibiting angiogenesis and treating angiogenesis-associated diseases' [patent_app_type] => utility [patent_app_number] => 11/897724 [patent_app_country] => US [patent_app_date] => 2007-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 21756 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20080280987.pdf [firstpage_image] =>[orig_patent_app_number] => 11897724 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6234970 [patent_doc_number] => 20100266674 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'L-ODDC PRODRUGS FOR CANCER' [patent_app_type] => utility [patent_app_number] => 12/310576 [patent_app_country] => US [patent_app_date] => 2007-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12389 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20100266674.pdf [firstpage_image] =>[orig_patent_app_number] => 12310576 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10838063 [patent_doc_number] => 08865737 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-21 [patent_title] => 'Antitumor agent for undifferentiated gastric cancer' [patent_app_type] => utility [patent_app_number] => 12/439339 [patent_app_country] => US [patent_app_date] => 2007-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 21380 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12439339 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4693103 [patent_doc_number] => 20080085874 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-10 [patent_title] => 'SMALL MOLECULE POTENTIATOR OF HORMONAL THERAPY FOR BREAST CANCER' [patent_app_type] => utility [patent_app_number] => 11/845554 [patent_app_country] => US [patent_app_date] => 2007-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 19301 [patent_no_of_claims] => 87 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0085/20080085874.pdf [firstpage_image] =>[orig_patent_app_number] => 11845554 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4734473 [patent_doc_number] => 20080051453 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-28 [patent_title] => 'Sorbic acid analog co-crystals' [patent_app_type] => utility [patent_app_number] => 11/895071 [patent_app_country] => US [patent_app_date] => 2007-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10759 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20080051453.pdf [firstpage_image] =>[orig_patent_app_number] => 11895071 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4955517 [patent_doc_number] => 20080188541 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-07 [patent_title] => 'In vivo assessment of toxicity and pharmacokinetics of methylglyoxal' [patent_app_type] => utility [patent_app_number] => 11/894736 [patent_app_country] => US [patent_app_date] => 2007-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8696 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0188/20080188541.pdf [firstpage_image] =>[orig_patent_app_number] => 11894736 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6638602 [patent_doc_number] => 20100173955 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => '4-SUBSTITUTED PHENOXYPHENYLACETIC ACID DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 12/438112 [patent_app_country] => US [patent_app_date] => 2007-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23016 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0173/20100173955.pdf [firstpage_image] =>[orig_patent_app_number] => 12438112 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4820269 [patent_doc_number] => 20080226588 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'Treating melanoma with bis(thiohydrazide amides)' [patent_app_type] => utility [patent_app_number] => 11/894270 [patent_app_country] => US [patent_app_date] => 2007-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16382 [patent_no_of_claims] => 69 [patent_no_of_ind_claims] => 41 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20080226588.pdf [firstpage_image] =>[orig_patent_app_number] => 11894270 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4765616 [patent_doc_number] => 20080176828 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-24 [patent_title] => 'Treating melanoma with BIS(THIOHYDRAZIDE AMIDES)' [patent_app_type] => utility [patent_app_number] => 11/894261 [patent_app_country] => US [patent_app_date] => 2007-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16569 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20080176828.pdf [firstpage_image] =>[orig_patent_app_number] => 11894261 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4658243 [patent_doc_number] => 20080027105 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-31 [patent_title] => 'Dosing Regimen of Flavopiridol for Treating Cancer`' [patent_app_type] => utility [patent_app_number] => 11/841241 [patent_app_country] => US [patent_app_date] => 2007-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6622 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20080027105.pdf [firstpage_image] =>[orig_patent_app_number] => 11841241 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6196778 [patent_doc_number] => 20110028536 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'METHODS AND COMPOSITIONS FOR TOPOISOMERASE I MODULATED TUMOR SUPPRESSION' [patent_app_type] => utility [patent_app_number] => 12/377498 [patent_app_country] => US [patent_app_date] => 2007-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11874 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20110028536.pdf [firstpage_image] =>[orig_patent_app_number] => 12377498 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4827132 [patent_doc_number] => 20080125485 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-29 [patent_title] => 'Use of 2,5-Dihydroxybenzene Derivatives for Treating Actinic Keratosis' [patent_app_type] => utility [patent_app_number] => 11/839508 [patent_app_country] => US [patent_app_date] => 2007-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 15088 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0125/20080125485.pdf [firstpage_image] =>[orig_patent_app_number] => 11839508 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4904661 [patent_doc_number] => 20080114075 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-15 [patent_title] => 'Use of 2,5-Dihydroxybenzene Derivatives for Treating Dermatitis' [patent_app_type] => utility [patent_app_number] => 11/839512 [patent_app_country] => US [patent_app_date] => 2007-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 12711 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0114/20080114075.pdf [firstpage_image] =>[orig_patent_app_number] => 11839512 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4734462 [patent_doc_number] => 20080051442 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-28 [patent_title] => 'AGENT FOR PREVENTION AND TREATMENT OF CANCER COMPRISING OXADIAZOLE UREA COMPOUND OBSTRUCTING ACTIVITY OF STAT' [patent_app_type] => utility [patent_app_number] => 11/839298 [patent_app_country] => US [patent_app_date] => 2007-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3033 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20080051442.pdf [firstpage_image] =>[orig_patent_app_number] => 11839298 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4904534 [patent_doc_number] => 20080113948 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-15 [patent_title] => 'Use of 2,5-Dihydroxybenzene Compounds and Derivatives for the Treatment of Psoriasis' [patent_app_type] => utility [patent_app_number] => 11/839520 [patent_app_country] => US [patent_app_date] => 2007-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 15234 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20080113948.pdf [firstpage_image] =>[orig_patent_app_number] => 11839520 [rel_patent_id] =>[rel_patent_doc_number] =>)